Published by Josh White on 20th November 2024
(Sharecast News) - Clinical-stage biopharmaceutical company Poolbeg Pharma announced on Wednesday that it has been granted a US patent for its 'Immunomodulator I' application.
URL: http://www.digitallook.com/dl/news/story/34703949/...